Project archive

Researchers participating in the RNA Therapeutics platform by the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD are studying circRNAs in human cardiomyocytes from patients that have experienced a SARS-CoV-2 infection.

The FingerKIt consortium develops personalized joint implants using AI-based 3D printing.

Disseminated tumor cells differ from the primary tumor. Therefore, knowing the mutation profile of a tumor is a valuable resource

As part of the EU-project TB Med, Fraunhofer ITEM and 12 other project partners are actively participating in the development of a test bed for medical devices of risk classifications IIb and III.

To enable better assessment of the safety also of future drugs, Fraunhofer ITEM researchers are developing innovative model systems for assessing immunomodulatory therapeutics.

Biomedical researchers are exploring alternative ways of obtaining such immune cells of human origin. Prof. Lachmann and his team have developed a new method laying a foundation for producing them in consistent quality and on large scale.

The Fraunhofer Attract program in the project “IMMUNITY – designer cells: novel immune cell platforms for health research” are developing novel manufacturing processes for different fully standardized immune cell products and cell-based immunotherapies.

Fraunhofer ITEM researchers use the ex-vivo model of the isolated perfused rat lung (IPL). In this alternative model, they studied the transition of a fluorescence-labeled substance into the perfusate, which served as blood substitute in this model. Two different methods were used to generate aerosols with different droplet sizes.

The web application Genealyzer abstracts away mathematical and programmatical details in order to enable a convenient and customizable analysis of microarray data for large-scale reproducibility studies.

The aim of an exploratory clinical study funded by the German Federal Environment Agency is to determine the respective threshold doses that trigger allergic symptoms in people allergic to ragweed or birch pollen.